ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,269Medicare Part D Prescriptions Filled, Including Refills

Rank: 14 out of 393

$645K Total Retail Price of All Prescriptions

Rank: 36 out of 393

1,127 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
26% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nevada
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 1,127 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

15% of this provider’s 1,127 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 16,408 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$35 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nevada
SIMVASTATIN 1,095 1,024 1 1
LISINOPRIL 878 785 2 2
LEVOTHYROXINE SODIUM 874 824 3 3
OMEPRAZOLE 834 755 4 6
AMLODIPINE BESYLATE 590 580 5 4
HYDROCODONE-ACETAMINOPHEN 550 490 S3 6 5
ALENDRONATE SODIUM 532 483 7 16
GABAPENTIN 468 386 8 15
METFORMIN HCL 377 334 9 7
LOSARTAN POTASSIUM 319 294 10 12
CITALOPRAM HBR 314 270 11 23
METOPROLOL TARTRATE 300 280 12 9
PRAVASTATIN SODIUM 292 271 13 18
ZOLPIDEM TARTRATE 277 256 14 11
WARFARIN SODIUM 265 233 15 17
ATENOLOL 265 245 15 13
LOVASTATIN 260 247 17 14
VENTOLIN HFA 259 247 18 42
LOSARTAN-HYDROCHLOROTHIAZIDE 250 223 19 31
GLYBURIDE 233 229 R 20 46
FUROSEMIDE 229 217 21 8
ATORVASTATIN CALCIUM 198 182 22 19
FENOFIBRATE 191 155 23 43
METOPROLOL SUCCINATE 188 172 24 22
CARVEDILOL 169 159 25 21
TRAMADOL HCL-ACETAMINOPHEN 162 148 26 139
GEMFIBROZIL 153 144 27 62
LISINOPRIL-HYDROCHLOROTHIAZIDE 151 149 28 24
HYDROCHLOROTHIAZIDE 151 148 28 10
ALLOPURINOL 149 149 30 26
DONEPEZIL HCL 142 141 31 34
RANITIDINE HCL 136 134 32 29
BENAZEPRIL HCL 134 122 33 40
TAMSULOSIN HCL 128 112 34 25
FLUTICASONE PROPIONATE 124 113 35 27
GLIPIZIDE 123 120 36 32
CLOPIDOGREL 117 105 37 33
SYMBICORT 115 114 38 96
CLONIDINE HCL 115 97 38 50
FLUOXETINE HCL 114 99 40 37
GLYBURIDE-METFORMIN HCL 111 89 R 41 125
SERTRALINE HCL 108 81 42 28
MELOXICAM 107 97 43 58
NAPROXEN 105 82 44 85
HYDRALAZINE HCL 104 86 45 64
TERAZOSIN HCL 103 103 46 38
METFORMIN HCL ER 94 78 47 63
OXYCODONE HCL 92 57 S2 48 36
POTASSIUM CHLORIDE 91 86 49 20
TRIAMCINOLONE ACETONIDE 88 72 50 94
DIGOXIN 87 87 51 66
TRAMADOL HCL 86 78 52 30
PLAVIX 81 79 53 51
FINASTERIDE 78 74 54 60
BENICAR HCT 74 74 55 161
LANTUS SOLOSTAR 73 56 56 74
CIPROFLOXACIN HCL 71 68 57 57
NAMENDA 70 70 58 59
TRAZODONE HCL 67 51 59 47
AMMONIUM LACTATE 66 54 60 265
PAROXETINE HCL 65 58 61 61
GLIPIZIDE ER 65 59 61 76
OXYCODONE HCL-ACETAMINOPHEN 63 45 S2 63 54
DILTIAZEM ER 63 63 63 107
BENAZEPRIL-HYDROCHLOROTHIAZIDE 62 60 65 179
GLIMEPIRIDE 61 58 66 39
AMITRIPTYLINE HCL 60 49 R 67 72
PEN NEEDLE 59 52 68 81
QVAR 58 57 69 101
TESTOSTERONE CYPIONATE 57 44 S3 70 283
IBUPROFEN 56 41 71 55
SPIRIVA 56 52 71 41
BACLOFEN 56 55 71 79
CARISOPRODOL 55 40 R 74 45
PREMARIN 53 53 R 75 157
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 19, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.